Christopher W. Allard

Statistics

Publications

Citations

101

H-Index

Active since

2019

Affiliations

Bristol-Myers Squibb (United States)(Current)

Christopher W. Allard is an author at Bristol-Myers Squibb (United States) specializing in medicinal chemistry, drug discovery, and cancer immunotherapy.

Publications per year

2019–2021

Publications

Discovery of Orally Active Isofuranones as Potent, Selective Inhibitors of Hematopoetic Progenitor Kinase 1

Andrew P. Degnan, Godwin Kumi, Christopher W. Allard et al. · ACS Medicinal Chemistry Letters · 2021 · 54 citations · Full text

Medicine, Medicinal Chemistry, Oncology +17

5,6,7,8-Tetrahydro-1,6-naphthyridine Derivatives as Potent HIV-1-Integrase-Allosteric-Site Inhibitors

Kevin M. Peese, Christopher W. Allard, Timothy P. Connolly et al. · Journal of Medicinal Chemistry · 2019 · 36 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Design, synthesis and SAR study of novel C2-pyrazolopyrimidine amides and amide isosteres as allosteric integrase inhibitors

Manoj Patel, Christopher Cianci, Christopher W. Allard et al. · Bioorganic & Medicinal Chemistry Letters · 2020 · 11 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

1–3 of 3